top of page

How Parimer Helped with Parkinson's Research

Parimer collaborated with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop a critical reagent required for the evaluation of novel imaging tracers for early Parkinson’s disease detection.

Untitled design (6).png

How Parimer Helped Onshore an Important International Drug to the U.S. 

The project included the redevelopment of a drug substance originally developed in Japan for the international market; However, it had never received US FDA approval. The client approached Parimer to develop a synthetic process to manufacture this drug substance in the USA and support the Chemistry, Manufacturing, and Controls (CMC) needed to get the drug through its Investigational New Drug filing (IND). 

bottom of page